These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10965650)

  • 21. Angiotensin-converting enzyme inhibition improves cardiac fatty acid metabolism in patients with congestive heart failure.
    Yamauchi S; Takeishi Y; Minamihaba O; Arimoto T; Hirono O; Takahashi H; Miyamoto T; Nitobe J; Nozaki N; Tachibana H; Watanabe T; Fukui A; Kubota I
    Nucl Med Commun; 2003 Aug; 24(8):901-6. PubMed ID: 12869823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical significance of 123I-BMIPP myocardial SPECT].
    Yamazaki J
    Kaku Igaku; 1998 Jul; 35(6):367-73. PubMed ID: 9753915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Myocardial uptake ratio of iodine-123 labeled beta-methyl iodophenylpentadecanoic acid (123I-BMIPP) in relation to the concentration of the substrates of energy].
    Tsuchimochi S; Tamaki N; Kawamoto M; Tadamura E; Fujita T; Nohara R; Matsumori A; Sasayama S; Yonekura Y; Konishi J
    Kaku Igaku; 1995 Jun; 32(6):579-86. PubMed ID: 7674568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Phase 3 study of beta-methyl-p-(123I)-iodophenyl-pentadecanoic acid, a myocardial imaging agent for evaluating fatty acid metabolism--a multi-center trial].
    Torizuka K; Yonekura Y; Nishimura T; Ohtake T; Bunko H; Tamaki N; Uehara T
    Kaku Igaku; 1992 Apr; 29(4):413-33. PubMed ID: 1602637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prediction of effect of beta-blocker therapy in patients with dilated cardiomyopathy by using 123I-BMIPP, 123I-MIBG scintigraphy].
    Inoue A; Yamazaki J; Nanjou S; Togane Y; Amano H
    Kaku Igaku; 2001 Mar; 38(2):99-104. PubMed ID: 11345771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perfusion and metabolic scintigraphy with (123)I-BMIPP in prognosis of cardiac resynchronization therapy in patients with dilated cardiomyopathy.
    Zavadovsky KV; Gulya MO; Lishmanov YB; Lebedev DI
    Ann Nucl Med; 2016 Jun; 30(5):325-33. PubMed ID: 26872805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predicting the effects on patients with dilated cardiomyopathy of beta-blocker therapy, by using iodine-123 15-(p-iodophenyl)-3- R,S-methylpentadecanoic acid (BMIPP) myocardial scintigraphy.
    Yoshinaga K; Tahara M; Torii H; Kihara K
    Ann Nucl Med; 1998 Dec; 12(6):341-7. PubMed ID: 9972371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Usefulness of (123)I-BMIPP with myocardial imaging for evaluation of the efficacy of drug therapy in patients with chronic heart failure.
    Watanabe K; Sekiya M; Tsuruoka T; Funada JI; Miyagawa M
    J Card Fail; 2001 Sep; 7(3):257-64. PubMed ID: 11561227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Electrocardiographic left ventricular hypertrophy without echocardiographic abnormalities evaluated by myocardial perfusion and fatty acid metabolic imaging].
    Narita M; Kurihara T
    J Cardiol; 2000 Jan; 35(1):33-40. PubMed ID: 10654248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Assessment of myocardial fatty acid metabolism in patients with vasospastic angina using 123I-BMIPP myocardial SPECT].
    Ito K; Sugihara H; Terada K; Matsumoto K; Taniguchi Y; Ohtsuki K; Miyazaki H; Nakagawa T; Azuma A; Maeda T
    Kaku Igaku; 1995 Oct; 32(10):1099-106. PubMed ID: 8523832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Relationship between ventricular arrhythmias and myocardial fatty acid metabolism in patients with coronary heart disease: evaluation using iodine-123 beta-methyl-p-iodophenyl-pentadecanoic acid].
    Mori H; Sakamoto T; Ueda Y; Yano K
    J Cardiol; 1999 Aug; 34(2):61-9. PubMed ID: 10466087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myocardial scintigraphy using iodine-123 15-(p-iodophenyl)-3-R, S-methylpentadecanoic acid predicts the response to beta-blocker therapy in patients with dilated cardiomyopathy but does not reflect therapeutic effect.
    Yoshinaga K; Tahara M; Torii H; Akimoto M; Kihara K; Tei C
    J Cardiol; 2000 May; 35(5):343-51. PubMed ID: 10834178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Usefulness of 123I-BMIPP myocardial scintigraphy for evaluation of the left ventricular function in patients with chronic heart failure].
    Watanabe K; Sekiya M; Tsuruoka T; Funada J; Miyagawa M; Kumano S
    Kaku Igaku; 1996 Jul; 33(7):743-51. PubMed ID: 8803443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Phase 2 study of beta-methyl-p-(123I)-iodophenyl-pentadecanoic acid, a myocardial imaging agent for evaluating myocardial fatty acid metabolism].
    Torizuka K; Yonekura Y; Nishimura T; Tamaki N; Uehara T
    Kaku Igaku; 1992 Mar; 29(3):305-17. PubMed ID: 1583804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous assessment of myocardial free fatty acid utilization and left ventricular function using 123I-BMIPP-gated SPECT.
    Inubushi M; Tadamura E; Kudoh T; Hattori N; Kubo S; Koshiji T; Nishimura K; Komeda M; Tamaki N; Konishi J
    J Nucl Med; 1999 Nov; 40(11):1840-7. PubMed ID: 10565779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Iodinated free fatty acid and 201T1 uptake in chronically hypoperfused myocardium: histologic correlation study.
    Kudoh T; Tadamura E; Tamaki N; Hattori N; Inubushi M; Kubo S; Magata Y; Nishimura K; Matsuda K; Konishi J
    J Nucl Med; 2000 Feb; 41(2):293-6. PubMed ID: 10688114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prognostic significance of 123I-metaiodobenzylguanidine scintigraphy in dilated cardiomyopathy].
    Suzuki Y; Toyama T; Kanda T; Tsukagoshi J; Isobe N; Nagaoka H; Kubota S; Iizuka T; Imai S; Nagai R
    Kaku Igaku; 1995 Nov; 32(11):1207-15. PubMed ID: 8558789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Assessment of myocardial fatty acid metabolism in patients with angina pectoris and diabetes mellitus using 123I-BMIPP myocardial scintigraphy].
    Ito K; Sugihara H; Tanabe T; Yuba T; Doue T; Adachi Y; Katoh S; Azuma A; Nakagawa M
    Kaku Igaku; 2001 Nov; 38(6):699-705. PubMed ID: 11806080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is I-123-beta-methyl-p-iodophenyl-methylpentadecanoic acid imaging useful to evaluate asymptomatic patients with hypertrophic cardiomyopathy? I-123 BMIPP imaging to evaluate asymptomatic hypertrophic cardiomyopathy.
    Narita M; Kurihara T
    Int J Cardiovasc Imaging; 2003 Dec; 19(6):499-510. PubMed ID: 14690189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myocardial metabolism of 123I-BMIPP during low-flow ischaemia in an experimental model: comparison with myocardial blood flow and 18F-FDG.
    Hosokawa R; Nohara R; Fujibayashi Y; Hirai T; Fujita M; Magata Y; Tadamura E; Konishi J; Sasayama S
    Eur J Nucl Med; 2001 Nov; 28(11):1630-9. PubMed ID: 11702104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.